K

KPX Lifescience Co Ltd
KOSDAQ:114450

Watchlist Manager
KPX Lifescience Co Ltd
KOSDAQ:114450
Watchlist
Price: 3 120 KRW -1.11% Market Closed
Market Cap: 62.4B KRW

KPX Lifescience Co Ltd
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

KPX Lifescience Co Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
K
KPX Lifescience Co Ltd
KOSDAQ:114450
Total Equity
â‚©35.7B
CAGR 3-Years
-14%
CAGR 5-Years
-10%
CAGR 10-Years
-4%
Samsung Biologics Co Ltd
KRX:207940
Total Equity
â‚©12.2T
CAGR 3-Years
12%
CAGR 5-Years
22%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Total Equity
â‚©501B
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Total Equity
â‚©54.5B
CAGR 3-Years
4%
CAGR 5-Years
56%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Total Equity
â‚©553.9B
CAGR 3-Years
32%
CAGR 5-Years
38%
CAGR 10-Years
45%
N
NanoEnTek Inc
KOSDAQ:039860
Total Equity
â‚©74B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
8%
No Stocks Found

KPX Lifescience Co Ltd
Glance View

KPX LIFESCIENCE Co., Ltd. engages in the production and sale of pharmaceutical and agricultural raw materials and intermediates. The company is headquartered in Yeosu, Jeollanam-Do and currently employs 61 full-time employees. The company went IPO on 2009-12-22. The Company’s products consist of AMZ and CCIM, which are used as crop protection materials; EDP-CL, which is a antibiotic used as ingredient of piperacillin; PM06, which is used for treatment of allergic diseases, and DSIC, which is used as pharmaceutical intermediate. The firm also provides antibiotics and others. The firm distributes its products within domestic market and to overseas markets, including Japan, the United States, Europe and others.

Intrinsic Value
1 992.49 KRW
Overvaluation 36%
Intrinsic Value
Price
K

See Also

What is KPX Lifescience Co Ltd's Total Equity?
Total Equity
35.7B KRW

Based on the financial report for Dec 31, 2024, KPX Lifescience Co Ltd's Total Equity amounts to 35.7B KRW.

What is KPX Lifescience Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
-4%

Over the last year, the Total Equity growth was -1%. The average annual Total Equity growth rates for KPX Lifescience Co Ltd have been -14% over the past three years , -10% over the past five years , and -4% over the past ten years .

Back to Top